Health Care·Biotechnology·$28.9B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.70 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.70 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed a cautious optimism about future prospects while acknowledging current operational challenges. They reiterated their commitment to improving efficiency and preparing for upcoming product launches.
Management emphasized ongoing efforts to improve operational efficiency.
They highlighted the importance of upcoming product launches.
There was a focus on long-term growth despite current challenges.
Natera Inc's earnings report showed a loss per share of $0.70, which was not compared against any consensus estimates. The stock reacted negatively, dropping 2.35%. This decline may reflect investor concerns over the lack of revenue data and guidance, despite management's focus on future growth and efficiency improvements.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
JD COM INC Class A ADR
May 8, 2017